| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15d42f684941d5b0617ca7764ebdff07 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-022 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 |
| filingDate |
1998-10-29^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11fde2ca3e61f5ac71cca4d6fbeabacc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18c1680c2ddf701d5688108ed5166e85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84f0a2d5d6d1b082fd951ef488a8f698 |
| publicationDate |
2000-02-24^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0009153-A1 |
| titleOfInvention |
Compositions and methods for treating lysosomal storage disease |
| abstract |
The present invention provides recombinant viral and non-viral vectors comprising a transgene encoding a biologically active human lysosomal enzyme that are able to infect and/or transfect and sustain expression of the biologically active human lysosomal enzyme transgene in mammalian cells deficient therein. In addition, methods are provided for providing a biologically active human lysosomal enzyme to cells deficient therein, which comprises introducing into the cells a vector comprising and expressing a transgene encoding the biologically active human lysosomal enzyme, wherein the vector is taken up by the cells, the transgene is expressed and biologically active enzyme is produced. The cells may be infected and/or transfected by the vector, dependent upon whether the vector is a viral vector and/or plasmid or the like. The invention also provides a method of supplying a biologically active human lysosomal enzyme to other distant cells deficient therein wherein the transfected and/or infected cells harboring the vector secrete the biologically active enzyme which is then taken up by the other deficient cells. In a preferred embodiment the present invention provides for sustained production of biologically human active α-galactosidase A in cells of Fabry individuals that are deficient in said enzyme. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0197829-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8945542-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8168587-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9315790-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11400141-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0197829-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10166274-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8569032-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10858638-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8663631-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7910545-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10407671-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10864255-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11560554-B2 |
| priorityDate |
1997-10-29^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |